Novo insulin sales
Executive Summary
Worldwide volume of Danish firm's insulin product line totaled almost $350 mil. in 1987 (translated from Danish krones at the end-of-the-year exchange rate). The human monocomponent insulin represented about $245 mil. of Novo's insulin sales. Company said its share of the insulin market "in the industrialized world" slipped to 34%, from 36% in 1986.